nakamoto Nobuhiro

Affiliation and department：

Research field (1)： Gastroenterology

Research keywords (2)：自己免疫性疾患 , 肝臓免疫

Research theme for competitive and other funds (6)：

2020 - 2023 Elucidation of the mechanism of NASH resolution via the gut-liver axis for future clinical application
2020 - 2022 Therapeutic effect of plasmacytoid dendritic cells transplantation for acute liver failure
2016 - 2019 Role of gut microbiota in the pathogenesis of primly sclerosing cholangitis
2013 - 2016 The interaction between the intestinal microbiota and hepatic macrophages in the pathogenesis of liver fibrosis
2012 - 2016 Comprehensive analysis of dysfunctional HCV specific CD8 T cell during persistent HCV infection

Show all

Papers (169)：

Yoko Kubosawa, Tomohisa Sujino, Kentaro Miyamoto, Atsuto Kayashima, Daisuke Minezaki, Kohei Morioka, Kentaro Iwata, Kurato Miyazaki, Teppei Masunaga, Mari Mizutani, et al. Distinctive duodenal microbiomes and bile acid profiles in duodenal tumor patients revealed by prospective observational study. Scientific reports. 2024. 14. 1. 18705-18705
Atsuto Kayashima, Tomohisa Sujino, Seiichiro Fukuhara, Kentaro Miyamoto, Yoko Kubosawa, Masataka Ichikawa, Shintaro Kawasaki, Kaoru Takabayashi, Eisuke Iwasaki, Motohiko Kato, et al. Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis. Hepatology communications. 2024. 8. 6
Masataka Ichikawa, Haruka Okada, Nobuhiro Nakamoto, Nobuhito Taniki, Po-Sung Chu, Takanori Kanai. The gut-liver axis in hepatobiliary diseases. Inflammation and regeneration. 2024. 44. 1. 2-2
Kenya Honda, Munehiro Furuichi, Takaaki Kawaguchi, Marie-Madlen Pust, Keiko Yasuma-Mitobe, Damian Plichta, Naomi Hasegawa, Takashi Ohya, Shakti Bhattarai, Satoshi Sasajima, et al. Rationally-defined microbial consortia suppress multidrug-resistant proinflammatory Enterobacteriaceae via ecological control. Research square. 2023
安藤裕子, 中代幸江, 楮柏松, 杉本真也, 山田洋平, 長谷川康, 春日良介, 田淵貴也, 近藤まゆ子, 森川麗, et al. COVID-19を契機にAcute-on-chronic肝不全(ACLF)の回復期にGLP-2アナログを導入した腸管機能不全関連肝障害(IFALD)の一例. 肝臓. 2023. 64. Suppl.3. A911-A911

ｍore...

MISC (134)：

吉松裕介, 筋野智久, 宮本健太郎, 原田洋輔, 三上洋平, 中本伸宏, 金井隆典. 臨床免疫領域における臓器・組織特異性青黛による大腸特異的な新規Tregの誘導. 日本臨床免疫学会総会プログラム・抄録集. 2022. 50回. 56-56
Ryosuke Kasuga, Po-Sung Chu, Nobuhito Taniki, Nobuhiro Nakamoto, Takanori Kanai. SERUM ALBUMIN LEVELS IMPROVE TRANSPLANT-FREE SURVIVAL PREDICTING PERFORMANCE OF CLIF-C ACLF SCORES IN CIRRHOTIC PATIENTS SUFFERED FROM AD/ACLF BEYOND 90 DAYS. HEPATOLOGY. 2022. 76. S914-S915
Nobuhito Taniki, Ryosuke Kasuga, Po-Sung Chu, Akihiro Yamaguchi, Hitomi Hoshi, Keisuke Ojiro, Fumihiko Kaneko, Nobuhiro Nakamoto, Takanori Kanai. PRIOR HISTORY OF LOCOREGIONAL THERAPY ASSOCIATES WITH TACE REFRACTORINESS IN PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA. HEPATOLOGY. 2022. 76. S1403-S1403
市川将隆, 中本伸宏, 金井隆典. 自己免疫性肝胆道疾患のCutting edge-病態理解と新規治療の開発原発硬化性胆管炎病態への腸内細菌の関与. 肝臓. 2022. 63. Suppl.1. A158-A158
Po-Sung Chu, Fumie Noguchi, Yasushi Hasegawa, Nobuhito Taniki, Rei Morikawa, Nobuhiro Nakamoto, Takanori Kanai. PREDICTION OF IMMUNOSUPPRESSION RESPONSIVENESS, SURVIVAL OUTCOME AND SEVERE INFECTIONS IN CORTICOSTEROIDS-TREATED PATIENTS WITH SEVERE ACUTE-ONSET AUTOIMMUNE HEPATITIS. HEPATOLOGY. 2021. 74. 774A-775A

ｍore...

Education (2)：

2000 - 2004 慶應義塾大学大学院博士課程
1992 - 1998 Keio University School of Medicine

Professional career (1)：

医学博士

Work history (1)：

2019/03 - 現在 Keio University School of Medicine Division of Gastroenterology and Hepatology Associate Professor

Awards (4)：

2015 - Liver Forum in Kyoto 研究奨励賞
2013 - Young Investigator Award, Keio University School of Medicine Alumni Association (Sanshikai)
2009 - Liver Forum in Kyoto 研究奨励賞
2009 - 日本肝臓学会Shering-Plough Award

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page